NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired the common units of XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP ("XPLR" or the "Company") (NYSE: XIFR) between September 27, 2023 and January 27, 2025, inclusive. Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors ...

Core Points - A shareholder has filed a securities class action lawsuit against Petco Health and Wellness Company, Inc. for misrepresentations regarding the company's ability to achieve sustainable and profitable growth [1][2] Group 1 - The lawsuit is on behalf of investors who purchased or acquired Petco securities between January 14, 2021, and June 5, 2025 [1] - Investors interested in joining the class action can contact the Investor Relations Manager for more information [2] - The deadline to file as a lead plaintiff is August 29, 2025, and participation does not require serving as a lead plaintiff [3] Group 2 - Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has represented large public and private pension funds [4] - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" and listed in The Legal 500 [4]

Core Viewpoint - A shareholder has filed a securities class action lawsuit against RxSight, Inc. for allegedly overstating product demand and failing to disclose sales declines due to adoption challenges and structural issues [1][2]. Group 1 - The lawsuit represents investors who purchased or acquired RxSight's securities between November 7, 2024, and July 8, 2025 [1]. - Defendants are accused of not disclosing significant challenges that affected the company's sales performance [2]. - The deadline to file as a lead plaintiff in the class action is September 22, 2025 [3]. Group 2 - Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has represented large public and private pension funds [4]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" and listed in The Legal 500 [4].

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired: (a) Alto Neuroscience, Inc. (“Alto” or the “Company”) (NYSE: ANRO) common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about February 2, 2024 (the “IPO” or “Offering”); and/or (b) Alto securities between February 2, ...

NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025, inclusive. For more information, submit a form at Neogen Corporation Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@bernlieb.com, or call u ...

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Capricor Therapeutics, Inc. for alleged misrepresentations regarding the safety and efficacy data of its lead drug candidate, deramiocel, during a specific time frame [1][2]. Group 1: Lawsuit Details - The lawsuit represents investors who purchased Capricor's securities between October 9, 2024, and July 10, 2025 [1]. - The allegations focus on misrepresentations related to the four-year safety and efficacy data from the Phase 2 HOPE-2 trial of deramiocel, aimed at treating cardiomyopathy associated with Duchenne muscular dystrophy [2]. Group 2: Legal Process - Investors wishing to serve as lead plaintiff must file necessary documents by September 15, 2025, with the role involving representation of other class members in the litigation [3]. - Participation as a class member does not require serving as lead plaintiff, and all legal representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [3]. Group 3: Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented both individual investors and large public and private pension funds [4]. - The firm has been recognized for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [4].

Core Viewpoint - A securities fraud class action lawsuit has been filed against XPLR Infrastructure, LP, alleging misrepresentations related to its business model and distribution growth rate [3][4]. Group 1: Lawsuit Details - The lawsuit was initiated in the United States District Court for the Southern District of California on behalf of investors who acquired XPLR common units between September 27, 2023, and January 27, 2025 [3]. - The allegations include violations of the Securities Exchange Act of 1934 against the Company and certain senior officers [3]. Group 2: Investor Information - Investors who purchased XPLR common units are encouraged to discuss their legal rights and options, with a deadline to file as lead plaintiff by September 8, 2025 [2][5]. - All representation in the lawsuit is on a contingency fee basis, meaning shareholders will not incur fees or expenses [5]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [6]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times [6].

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of Centene Corporation (NYSE: CNC)?Did you purchase your shares between December 12, 2024 and June 30, 2025, inclusive?Did you lose money ...

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Centene Corporation for alleged misrepresentations regarding the company's enrollment and morbidity rates during a specified period [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased or acquired Centene's securities between December 12, 2024, and June 30, 2025 [1]. - Defendants are accused of making misrepresentations about the state of Centene's enrollment and morbidity rates [2]. Group 2: Lead Plaintiff Information - Interested parties wishing to serve as lead plaintiff must file papers by September 8, 2025 [3]. - Serving as lead plaintiff is not a requirement for sharing in any potential recovery, and shareholders can remain absent class members if they choose not to take action [3]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [4]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [4].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Petco Health and Wellness Company, Inc. for alleged misrepresentations regarding its ability to achieve sustainable and profitable growth [3]. Group 1: Lawsuit Details - The lawsuit was initiated in the United States District Court for the Southern District of California on behalf of investors who purchased Petco securities between January 14, 2021, and June 5, 2025 [3]. - The allegations include violations of the Securities Exchange Act of 1934 against the Company and certain senior officers [3]. Group 2: Legal Participation - Investors wishing to serve as lead plaintiffs must file necessary documents by August 29, 2025, although participation as a lead plaintiff is not required to share in any potential recovery [4]. - All legal representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [4]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since its inception in 1993 and has represented both individual investors and large public and private pension funds [5]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [5].